Skip to NavigationSkip to content

opioid crisis

Jonathan Sackler, co-owner of Purdue Pharma, dies from cancer

Photo by John9474 - Eigenes Werk

Jonathan Sackler, son of Purdue Pharma founder Raymond Sackler, died on 30 June from cancer, according to the company. He was 65.

Jonathan served as an executive board member for Purdue but had recently stepped down, while retaining his ownership of the company. He had also been Vice President in the past, but was not as involved as his brother Richard who was Chief Executive.

Top Ten most popular articles on Pharmafile.com this week

The coronavirus is again in the news, with the Indian government considering banning exports of medicine as the epidemic threatens vital pharmaceutical supplies from China. This is not just a regional issue, as Europe and the US are also having their drug production pipeline disrupted by the epidemic. 

In UK news, NICE gives initial ‘no’ to NHS England for kidney cancer drug, while experts have called on the organisation to ban the sale of over the counter codeine. 

Experts call on NICE to recommended a ban on OTC codeine sales

Experts have called for a ban on the sale of over the counter codeine as NICE is set to publish its draft guidance for the management of chronic pain next week.

Read the January/February 2020 edition of Pharmafocus online now!

Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got done – or at least, the first step in a long process – and the UK will leave the European Union at 11pm on 31 January.

It’s a path paved with uncertainty, but it does provide clarity for business and industry which have been previously unable to plan ahead in such a divided climate.

Judge overseeing Purdue Pharma bankruptcy approves $1.3 million bonus for CEO

Purdue Pharma’s CEO Craig Landau can receive a $1.3 million bonus, ruled a judge.

Judge Robert Drain said the company was justified in giving Landau the bonus as it would keep him as CEO of the company.

Connecticut and the 23 other non-consenting states who have not agreed to settlement terms with Purdue, had strongly opposed the bonus.

FDA panel votes against Nektar opioid painkiller

FDA unanimously voted against Nektar Therapeutics opioid pankiller (NKTR-181) for chronic lower back pain, prompting the company to withdraw its application.

It voted 27-0 against the approval over concerns of people abusing the drug. They also felt that there was a lack of data to determine the possible abuse when snorted or injected and its potential for liver toxicity.

Rochester Drug Cooperative ceases opioid sales following criminal charges

The Rochester Drug Cooperative (RDC) has announced it will no longer distribute opioid medications after two of its executives were charged with illegally distributing opioids and conspiring to defraud the FDA.

The RDC said in a statement that: "The ever-increasing expenses associated with the legal and regulatory compliance for this segment of drugs are simply not sustainable. While these specific drugs represent a relatively small percent of total sales, they account for significant legal and compliance."

Pharmacies argue that prescribers bear ultimate responsibility for the opioid crisis

Pharmacy chains have argued in federal court that doctors and healthcare practitioners who write prescriptions bear ultimate responsibility for the improper distribution of opioids to patients, not the chains themselves.

The filings were submitted Monday to the federal judge in Cleveland, who has been overseeing national opioid lawsuits. It asked the judge to rule in their favour and reject the claims bought by Ohio county against them.

Sackler family withdrew $10 billion from Purdue Pharma while legal pressure mounted, audit shows

An audit commissioned by Purdue Pharma, to help navigate its bankruptcy, indicates that members of the Sackler family withdrew $10.7 billion from the company and distributed it amongst its trusts and overseas holding companies, according to reporting by The New York Times.

Sacklers could give up Purdue Pharma and settle 2,000 lawsuits for $10-12 billion, proposal says

The Sackler family are offering to settle more than 2,000 opioid crisis lawsuits for between $10-12 billion, according to NBC.

Sackler family lawyers said in a confidential meeting in Cleveland on 20 August that the family would settle lawsuits brought about by states, cities and counties for a sum of between $10 billion and $12 billion.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches